Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.5250
+0.0250 (4.76%)
Aug 15, 2025, 4:35 PM GMT+1
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 7.95 million as of August 15, 2025. Its market cap has decreased by -57.73% in one year.
Market Cap
7.95M
Enterprise Value
5.00M
Revenue
2.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 7.95M, a decrease of -84.64%. That is a compound annual growth rate of -32.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 7.95M | -15.46% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | 82.92M | 60.27% |
| Nov 3, 2020 | 51.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.76B |
| GSK plc | 57.45B |
| Haleon | 32.11B |
| Smith & Nephew | 11.74B |
| ConvaTec Group | 4.66B |
| Hikma Pharmaceuticals | 3.97B |
| HUTCHMED (China) | 2.09B |
| Oxford Nanopore Technologies | 2.04B |